Medpace Holdings (MEDP) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Medpace Holdings (MEDP) is Neutral.

The composite score behind that read is +0.08, weighing +0.12 of bullish evidence against -0.21 bearish.

Medpace Holdings last closed at $612.05, +1.55% on the session.

Against the IVW growth benchmark the position is +0.75% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

6 graded predictions for MEDP so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Medpace Holdings in the 23rd percentile on valuation and the 96th percentile on return on equity, where 100 is best.

Medpace Holdings is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $16.82B.

StockMap tracks Medpace Holdings as the 10th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Medpace Holdings ranks 14th of 41 in the group, against a group median of +0.06.